Structural Identification and Functional Consequences of Different Amyloid Strains in Alzheimer's Disease
阿尔茨海默病中不同淀粉样蛋白菌株的结构鉴定和功能后果
基本信息
- 批准号:10405031
- 负责人:
- 金额:$ 62.66万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-09-30 至 2024-05-31
- 项目状态:已结题
- 来源:
- 关键词:Academic Medical CentersAddressAgeAge of OnsetAgingAlzheimer&aposs DiseaseAmyloidAmyloid beta-ProteinAmyloid depositionApolipoprotein EAtomic Force MicroscopyBiological MarkersBrainCell Culture TechniquesCellsCharacteristicsClinicalDementiaDepositionDiseaseEarly Onset Alzheimer DiseaseEarly Onset Familial Alzheimer&aposs DiseaseFluorescence SpectroscopyGenderGenetic PolymorphismGenotypeGossypiumGrowthHumanIn VitroInflammatory ResponseKnowledgeLate Onset Alzheimer DiseaseLocationMeasurementMicrogliaMorphologyMutationNMR SpectroscopyNetherlandsOnset of illnessPathologicPathologyPeptidesPharmaceutical PreparationsProteinsRattusReportingSamplingSeedsSenile PlaquesSpectroscopy, Fourier Transform InfraredSpectrum AnalysisStructureSymptomsTissue SampleToxic effectTransmission Electron MicroscopyWoolamyloid formationbeta pleated sheetbrain parenchymabrain tissuedisorder subtypefamilial Alzheimer diseasegenetic testingillness lengthin vivomicroscopic imagingneuroimagingneuroinflammationpresenilin-2solid state nuclear magnetic resonancetau Proteins
项目摘要
Alzheimer's disease is associated with the deposition of amyloid in the brain during aging. Since the
correlation between amyloid formation and AD was originally made, it has been recognized that there are
many subtypes and forms that the disease can take. For example, accumulation of the amyloid β-protein (Aβ)
in the brain parenchyma is the hallmark of Alzheimer's disease (AD). Nevertheless, there is a poor
understanding as to why amyloid forms, and it is not known whether there are unique structural motifs that
promote the distinct pathological consequences leading to dementia. The focus of this proposal is to fill this
critical void in knowledge. Accordingly, the overall hypothesis of this proposal is that the Aβ peptides forming
amyloid with distinct subtypes have distinct structures that determine their location and pathology. To address
this hypothesis we propose two specific aims.
First, we plan to isolate amyloid from different subtypes of post mortem brain tissue of late-onset AD and early-
onset familial AD. We plan to compare five different amyloid plaque subtypes: typical AD, atypical AD, cotton
wool, early-onset AD (EOAD) and very early-onset AD (VEOAD). The last two subtypes are associated with
familial AD mutations. Clinical information is available concerning age and gender, age of onset and duration of
disease, course and symptoms of the disease, medication and ApoE genotype. In the EOAD and VEOAD
cases genetic testing was performed for APP, PSEN 1, PSEN2 and tau. For most cases, biomarkers in CSF
and neuroimaging results are available. The isolated amyloid will serve as seeds to nucleate fibril growth for in
vitro studies. The structure and polymorphism of the fibrils will be assessed by complementary structural
approaches including solid-state NMR spectroscopy, Fourier transform infrared spectroscopy, transmission
electron microscopy, and atomic force microscopy.
Using the amyloid isolated from the five different subtypes of AD, we will assess the biofunctional
consequences of the different strains using three approaches. First, we will assess the differences in the
inflammatory response and cell toxicity due to different fibril forms using microglial cell cultures. Second, we
will determine the influence of amyloid strains on promoting neuroinflammation. Third, we will determine the
influence of amyloid strains on assembly and propagation in rat brain.
The overall objective is to correlate pathologies (biofunctional consequences) of different amyloid subtypes
between cell culture, rat brain and human brain, and to relate these pathologies with specific structural
characteristics of the Aβ fibrils that are associated with the isolated amyloid from each subtype.
阿尔茨海默病与衰老过程中大脑中淀粉样蛋白的沉积有关。自
项目成果
期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Clinical and Pathological Phenotypes of LRP10 Variant Carriers with Dementia.
- DOI:10.3233/jad-200318
- 发表时间:2020
- 期刊:
- 影响因子:0
- 作者:Vergouw LJM;Geut H;Breedveld G;Kuipers DJS;Quadri M;Netherlands Brain Bank;Rozemuller AJM;van Swieten JC;de Jong FJ;van de Berg WDJ;Bonifati V
- 通讯作者:Bonifati V
The coarse-grained plaque: a divergent Aβ plaque-type in early-onset Alzheimer's disease.
- DOI:10.1007/s00401-020-02198-8
- 发表时间:2020-12
- 期刊:
- 影响因子:12.7
- 作者:Boon BDC;Bulk M;Jonker AJ;Morrema THJ;van den Berg E;Popovic M;Walter J;Kumar S;van der Lee SJ;Holstege H;Zhu X;Van Nostrand WE;Natté R;van der Weerd L;Bouwman FH;van de Berg WDJ;Rozemuller AJM;Hoozemans JJM
- 通讯作者:Hoozemans JJM
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
STEVEN Owen SMITH其他文献
STEVEN Owen SMITH的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('STEVEN Owen SMITH', 18)}}的其他基金
Structural Identification and Functional Consequences of Different Amyloid Strains in Alzheimer's Disease
阿尔茨海默病中不同淀粉样蛋白菌株的结构鉴定和功能后果
- 批准号:
9672144 - 财政年份:2018
- 资助金额:
$ 62.66万 - 项目类别:
Structural Identification and Functional Consequences of Different Amyloid Strains in Alzheimer's Disease
阿尔茨海默病中不同淀粉样蛋白菌株的结构鉴定和功能后果
- 批准号:
9789805 - 财政年份:2018
- 资助金额:
$ 62.66万 - 项目类别:
Structural Identification and Functional Consequences of Different Amyloid Strains in Alzheimer's Disease
阿尔茨海默病中不同淀粉样蛋白菌株的结构鉴定和功能后果
- 批准号:
10176329 - 财政年份:2018
- 资助金额:
$ 62.66万 - 项目类别:
Understanding the Origins of Amyloid Deposition in Cerebral Amyloid Angiopathy
了解脑淀粉样血管病中淀粉样蛋白沉积的起源
- 批准号:
9919003 - 财政年份:2017
- 资助金额:
$ 62.66万 - 项目类别:
Understanding the Origins of Amyloid Deposition in Cerebral Amyloid Angiopathy
了解脑淀粉样血管病中淀粉样蛋白沉积的起源
- 批准号:
9251922 - 财政年份:2016
- 资助金额:
$ 62.66万 - 项目类别:
Mechanism of inhibition of APP processing and amyloid formation
APP 加工和淀粉样蛋白形成的抑制机制
- 批准号:
8332308 - 财政年份:2006
- 资助金额:
$ 62.66万 - 项目类别:
Structure-inhibition of amyloid oligomers and fibrils
淀粉样蛋白寡聚体和原纤维的结构抑制
- 批准号:
7866473 - 财政年份:2006
- 资助金额:
$ 62.66万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 62.66万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 62.66万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 62.66万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 62.66万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 62.66万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 62.66万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 62.66万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 62.66万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 62.66万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 62.66万 - 项目类别:
Research Grant